Drugs / Hospital compounded "All in one" emulsion
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03792100 Comparator | Jan 2019 → Jan 2020 | — | Fresenius Kabi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hospital compounded "All in one" emulsion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03792100 ↗ |
| Route | Intravenous | “continuously infused intravenously via central venous access” NCT03792100 ↗ |